<code id='262B59E370'></code><style id='262B59E370'></style>
    • <acronym id='262B59E370'></acronym>
      <center id='262B59E370'><center id='262B59E370'><tfoot id='262B59E370'></tfoot></center><abbr id='262B59E370'><dir id='262B59E370'><tfoot id='262B59E370'></tfoot><noframes id='262B59E370'>

    • <optgroup id='262B59E370'><strike id='262B59E370'><sup id='262B59E370'></sup></strike><code id='262B59E370'></code></optgroup>
        1. <b id='262B59E370'><label id='262B59E370'><select id='262B59E370'><dt id='262B59E370'><span id='262B59E370'></span></dt></select></label></b><u id='262B59E370'></u>
          <i id='262B59E370'><strike id='262B59E370'><tt id='262B59E370'><pre id='262B59E370'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:hotspot    Page View:414
          close-up of psoriasis on a hand. -- biotech coverage from STAT
          A close-up of psoriasis on a hand. Adobe

          San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

          Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

          advertisement

          Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          What American doctors can learn from their Israeli counterparts
          What American doctors can learn from their Israeli counterparts

          IsraelisgatherinTelAvivforthe34thconsecutiveweektoprotestagainstplansbyPrimeMinisterBenjaminNetanyah

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

          InsitroCEOandfounderDaphneKollerNeilsonBarnard/GettyImagesforTheNewYorkTimesSANFRANCISCO—Ittookonlya